Financhill
Back

Gilead Sciences Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
62

GILD
Gilead Sciences

Last Price:
90.20
Seasonality Move:
8.18%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Gilead Sciences Price Quote

$90.20
-0.02 (0.4%)
(Updated: November 6, 2024 at 5:12 AM ET)

Gilead Sciences Key Stats

Buy
62
Gilead Sciences (GILD) is a Buy

Day range:
$89.01 - $90.39
52-week range:
$62.07 - $90.71
Dividend yield:
3.39%
P/E ratio:
20.05
P/S ratio:
4.06
P/B ratio:
6.14%

Volume:
3.8M
Avg. volume:
5.3M
1-year change:
10.58%
Market cap:
$112.3B
Revenue:
$27.1B
EPS:
$0.82

How Much Does Gilead Sciences Make?

Is Gilead Sciences Growing As A Company?

  • What Is Gilead Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Gilead Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.55%

Gilead Sciences Stock Price Performance

  • Did Gilead Sciences Stock Go Up Last Month?
    Gilead Sciences share price went up by 6.66% last month
  • Did GILD's Share Price Rise Over The Last Year?
    GILD share price rose by 10.58% over the past 1 year

What Is Gilead Sciences 52-Week High & Low?

Gilead Sciences Price To Free Cash Flow

Is It Risky To Buy Gilead Sciences?

  • How Much Debt Does Gilead Sciences Have?
    Total long term debt quarterly is $23.4B
  • How Much Cash Does Gilead Sciences Have?
    Cash and short term investments quarterly total is $2.8B
  • What Is Gilead Sciences’s Book Value Per Share?
    Book value per share is 14.67

Is Gilead Sciences Cash Flow Positive?

  • What Is GILD Cash Flow From Operations?
    Cash flow from operations (TTM) is $7.5B
  • What Is Gilead Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$6.9B
  • What Is Gilead Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.5B

Gilead Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    GILD return on invested capital is 2.34%
  • What Is Gilead Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is 1.78%
  • What Is GILD Return On Equity?
    ROE is a measure of profitability and is 5.18%

Gilead Sciences Earnings Date & Stock Price

Gilead Sciences Competitors

  • Who Are Gilead Sciences's Competitors?
    Below is a list of companies who compete with Gilead Sciences or are related in some way:
    • Amgen Inc (AMGN)
    • Bristol-Myers Squibb Co (BMY)
    • Eli Lilly and Co (LLY)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)

Gilead Sciences Dividend Yield

Gilead Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 55.42% 25.74%
Revenue: 5.36% 3.25%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 12
Sell Recommendations: 0
Price Target: 88.79
Downside from Last Price: -1.59%

Major Shareholders

  • How many GILD shares are owned by institutional investors?
    1.7B GILD shares are owned by institutional investors
  • How many GILD shares are owned by insiders?
    8.4M GILD shares are owned by insiders